NCT06084832 Smartphone Application for University Students With Binge Drinking Behavior
| NCT ID | NCT06084832 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Condition | Alcohol Drinking |
| Study Type | INTERVENTIONAL |
| Enrollment | 628 participants |
| Start Date | 2023-10-01 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 628 participants in total. It began in 2023-10-01 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Alcohol use is a causal factor in more than 200 diseases and injury conditions (see ICD-10) and in France, alcohol is the first cause of hospitalization. Binge drinking (BD) has emerged as a major public health issue among student populations and is associated with negative consequences and social, cognitive and brain alterations. More than half of French university students have reported BD in the past month and are at increased risk of several alcohol-related consequences such as memory and sleep impairments, and reduced quality of life. BD is also a major risk factor in the development of alcohol addiction, with individual and environmental factors playing a role that is still poorly understood. Moreover, most students and young adults are reluctant to seek interventions when it is provided by health care professionals (only 4-5%) and have poor insight with regard to their alcohol use patterns / habits. Thus, there is an urgent need for developing effective prevention and intervention programs to reduce alcohol drinking in students. Recent studies have demonstrated that new types of technology-delivered interventions are promising tools for addressing unhealthy alcohol use. For example, an uncontrolled trial pilot study using a smartphone application-delivered intervention produced a reduction in both number of drinks per week and BD from baseline to 3-month follow-up. A recent review also showed significant outcomes of a mobile health intervention for self-control of unhealthy alcohol use. The investigators hypothesize that a timeline follow-back and personalized feedback based on the use of a mobile application can reduce excessive alcohol intake at 3-months. This study will provide scientific knowledge about BD in students, but also regarding a new type of intervention that could be effective for prevention in non-treatment seeking individuals and reducing the severity of health problems associated with excessive alcohol intake.
Eligibility Criteria
Inclusion Criteria: * Students between 18 and 25 years old * AUQ score greater than or equal to 24, and AUDIT score greater than or equal to 3 for its first 3 items. Drinking details with the DDQ when necessary. * BD behavior: at least one occasion with 6 or more drinks in the last 3 months. * Consent to be included in the study * Affiliated to social security Exclusion Criteria: * Not having a smartphone with an Apple or Android system. * Previous use of the MyDéfi smartphone application * Declaration of a psychiatric / neurologic condition * Pregnant, parturient or breastfeeding woman * Subject under guardianship, curators or restricted under public law
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06084832 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying Alcohol Drinking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06084832 currently recruiting?
Yes, NCT06084832 is actively recruiting participants. Contact the research team at mickael.naassila@u-picardie.fr for enrollment information.
Where is the NCT06084832 trial being conducted?
This trial is being conducted at Amiens, France.
Who is sponsoring the NCT06084832 clinical trial?
NCT06084832 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 628 participants.